A Story Half Told

Metastatic Breast Cancer: A Story Half Told is a global educational initiative in which Pfizer is aiming to increase understanding about metastatic breast cancer. This initiative comes at a time when leaders within the breast cancer community are acknowledging worldwide that progress in mBC has not kept pace with the evolution witnessed in managing early breast cancer.

As part of A Story Half Told – and for the first time in Ireland – we have undertaken a female-only, nationally representative survey to gauge awareness of mBC. As detailed in this report, the research highlights some worrying misconceptions.

Many Irish women know little about metastatic breast cancer, including the fact that early detection does not help survival for these patients [iii].

A Story Half Told is part of Pfizer’s ongoing commitment to support everyone living with breast cancer – a commitment that has led to, for example, supporting essential fundraising activities for the Marie Keating Foundation, as well as supporting services for patients with mBC through Europa Donna Ireland and the Irish Cancer Society.

iii: Metastatic breast cancer survey, sponsored by Pfizer Oncology and conducted by iReach Insights June 2016.

Download the Report Here